---
schema_version: "secwatch.filing_event.v1"
accession: "0001831283-22-000079"
form_type: "8-K"
ticker: "LIANY"
cik: "0001831283"
company_name: "LianBio"
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:38:01.992746+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# LianBio President and Chief Strategy Officer Debra Yu resigns effective Jan 1, 2023

## Summary
- Debra Yu, President and CSO, resigns effective Jan 1, 2023 to pursue other business opportunities.
- Yu entered a consulting agreement with LianBio from Jan 1 to June 30, 2023 to facilitate transition.
- Separation agreement includes 12 months base salary, 14-month lump sum, and extended option exercisability.

## SEC filing metadata
- accession: 0001831283-22-000079
- form_type: 8-K
- ticker: LIANY
- cik: 0001831283
- company_name: LianBio
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831283/000183128322000079/0001831283-22-000079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831283/000183128322000079/lian-20221209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001831283-22-000079
- JSON: https://secwatch.observer/filing/0001831283-22-000079.json
- Plain text: https://secwatch.observer/filing/0001831283-22-000079.txt

## Key facts
- Executive change
  Debra Yu resigned as President and Chief Strategy Officer at LianBio.
  - Action: resigned
  - Role: President and Chief Strategy Officer
  source text: Debra Yu, the Company’s President and Chief Strategy Officer, has decided to resign from the Company, effective January 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831283/000183128322000079/0001831283-22-000079-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.